These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12172386)

  • 1. Assessment of acetazolamide reactivity in cerebral blood flow using spectral analysis and technetium-99m hexamethylpropylene amine oxime.
    Takasawa M; Murase K; Oku N; Yoshikawa T; Osaki Y; Imaizumi M; Matsuzawa H; Fujino K; Hashikawa K; Kitagawa K; Hori M; Matsumoto M
    J Cereb Blood Flow Metab; 2002 Aug; 22(8):1004-9. PubMed ID: 12172386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectral analysis of 99mTc-HMPAO for estimating cerebral blood flow: a comparison with H2(15)O PET.
    Takasawa M; Murase K; Oku N; Kawamata M; Nagayoshi M; Imaizumi M; Yoshikawa T; Osaki Y; Kimura Y; Kajimoto K; Kitagawa K; Hori M; Hatazawa J
    Ann Nucl Med; 2004 May; 18(3):243-9. PubMed ID: 15233286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative approach to estimation of the brain perfusion index for measurement of cerebral blood flow using technetium-99m compounds.
    Murase K; Inoue T; Fujioka H; Ishimaru Y; Akamune A; Yamamoto Y; Mochizuki T; Ikezoe J
    Eur J Nucl Med; 1999 Oct; 26(10):1333-9. PubMed ID: 10541833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic determination of brain perfusion index for measurement of cerebral blood flow using spectral analysis and 99mTc-HMPAO.
    Takasawa M; Murase K; Oku N; Kawamata M; Imaizumi M; Yoshikawa T; Osaki Y; Paul AK; Kitagawa K; Matsumoto M; Hori M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1443-6. PubMed ID: 12397462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].
    Makino K; Masuda Y; Gotoh S
    Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver variability of cerebral blood flow measurements obtained using spectral analysis and technetium-99m labeled compounds.
    Takasawa M; Murase K; Oku N; Kawamata M; Nagayoshi M; Osaki Y; Imaizumi M; Yoshikawa T; Kitagawa K; Hori M; Hatazawa J
    Ann Nucl Med; 2003 May; 17(3):255-9. PubMed ID: 12846551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular reactivity to acetazolamide in alert patients with cerebral infarction: usefulness of first-pass radionuclide angiography using 99m Tc-HMPAO in monitoring cerebral haemodynamics.
    Chang CC; Kanno H; Yamamoto I; Kuwana N
    Nucl Med Commun; 2001 Oct; 22(10):1119-22. PubMed ID: 11567185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
    Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
    J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A quantitative approach to the rCBF response to acetazolamide using 99mTc-HMPAO and graphical analysis].
    Terada H; Watanabe N; Gomi T; Murakami S; Nagamoto M; Kuwajima A; Hiramatsu Y; Iwabuchi S; Ushikubo Y; Samejima H
    Kaku Igaku; 1994 Apr; 31(4):367-71. PubMed ID: 8196233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive methods for absolute cerebral blood flow measurement using 99mTc-ECD: a study in healthy volunteers.
    Van Laere K; Dumont F; Koole M; Dierckx R
    Eur J Nucl Med; 2001 Jul; 28(7):862-72. PubMed ID: 11504083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of blood flow reserve using 99mTc-HMPAO in carotid stenosis.
    Garai I; Varga J; Szomják E; Tóth C; Bánk J; Ficzere A; Olvasztó S; Galuska L
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):216-20. PubMed ID: 11926383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraction of arterial input function for measurement of brain perfusion index with 99mTc compounds using fuzzy clustering.
    Murase K; Nagayoshi M; Uenishi Y; Kawamata M; Yamazaki Y; Takasawa M; Oku N; Hatazawa J
    Nucl Med Commun; 2004 Mar; 25(3):299-303. PubMed ID: 15094450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.
    Matsuda H; Yagishita A; Tsuji S; Hisada K
    Eur J Nucl Med; 1995 Jul; 22(7):633-7. PubMed ID: 7498224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide.
    Jiménez-Bonilla JF; Quirce R; Hernández A; Vallina NK; Guede C; Banzo I; Amado JA; Carril JM
    Eur J Nucl Med; 2001 Nov; 28(11):1647-55. PubMed ID: 11702106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of the brain perfusion index for measuring cerebral blood flow using technetium-99m compounds.
    Murase K; Fujioka H; Inoue T; Ishimaru Y; Akamune A; Yamamoto Y; Mochizuki T; Ikezoe J
    Eur J Nucl Med; 2001 Nov; 28(11):1640-6. PubMed ID: 11702105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.
    Matsuda H; Tsuji S; Shuke N; Sumiya H; Tonami N; Hisada K
    Eur J Nucl Med; 1993 May; 20(5):391-401. PubMed ID: 8519258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Perfusion Imaging Under Acetazolamide Challenge for Detection of Impaired Cerebrovascular Reserve Capacity: Positive Findings with
    Acker G; Lange C; Schatka I; Pfeifer A; Czabanka MA; Vajkoczy P; Buchert R
    J Nucl Med; 2018 Feb; 59(2):294-298. PubMed ID: 28729429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Eur J Nucl Med; 1996 Jun; 23(6):683-9. PubMed ID: 8662103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia.
    Pávics L; Grünwald F; Reichmann K; Horn R; Kitschenberg A; Hartmann A; Menzel C; Schomburg AG; Overbeck B; Csernay L; Biersack HJ
    Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deadtime loss on quantitative measurement of cerebral blood flow with technetium-99m hexamethylpropylene amine oxime.
    Inoue Y; Momose T; Ohtake T; Asai S; Yoshikawa K; Nishikawa J; Sasaki Y
    Eur J Nucl Med; 1997 Nov; 24(11):1418-21. PubMed ID: 9371876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.